Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1535 per EA under NDC 27241016901. Its NADAC has been published 329 times since May 6, 2020.
FDA first approved this application on Sep 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241016901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212624FDA Approved
9/13/2019
TE Code
AB
On Market Since
12/20/2019
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 329 times since May 6, 2020, and over the history we have for it it has declined 69.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.5022 (Jun 10, 2020) |
| All-time low | $0.1165 (Nov 20, 2024) |
| 52-week high | $0.1606 |
| 52-week low | $0.1441 |
| Median price | $0.2796 |
| Average price | $0.2906 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 329 |
| Tracking since | May 6, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.1535 per EA (NDC 27241016901), effective Aug 19, 2026.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 69.3%. It has been tracked across 329 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since May 6, 2020, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.5022 (Jun 10, 2020), with a median of $0.2796 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXEPIN 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 27241016901) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.